The Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin trial
JUPITER is a completed, randomized, double-blind, placebo-controlled trial of rosuvastatin 20 mg daily in the prevention of cardiovascular disease.
- Start Year
- End Year
- Study design
- Clinical trial cohort
- Follow Up
- A median of 1.9 years follow up
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Men who were at least 50 years old and women at least 60 years old were eligible for the trial (no history of cardiovascular disease)
Availability of data and biosamples
No coverage data about the variables classifications are available.